A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity
Background. Solute carrier family 12 member 5 (SLC12A5) has been reported to play an oncogenic role in certain malignancies. Its prognostic roles and immune mechanisms of action in human cancers, however, remain largely unknown. Methods. Data derived from TCGA, GEPIA, and TIMER databases were utiliz...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2021-01-01
|
| Series: | Disease Markers |
| Online Access: | http://dx.doi.org/10.1155/2021/3062606 |